INTRODUCTION
Phosphorylation of serine 10 of histone H3 (H3S10p) by Aurora kinase B (AURKB) is a well-established chromatin modification of mitotic chromosomes (Adams et al., 2001; Honda et al., 2003) . During mitosis, H3S10 phosphorylation acts in concert with H3K14 acetylation (H3K14ac) and induces the dissociation of heterochromatin protein 1 (HP1) from chromatin (Fischle et al., 2005; Mateescu et al., 2004) . The latter protein interacts with the SUV39H1 and SUV39H2 histone methylases (referred to here as SUV39H) that catalyze the di-and trimethylation of histone H3 at lysine 9 (H3K9me2/3) in pericentric heterochromatin (Aagaard et al., 1999; Mü ller-Ott et al., 2014; Yamamoto and Sonoda, 2003) . The H3K9me2/3 modification promotes HP1 binding to nucleosomes carrying this modification via its chromodomain that recognizes this mark (Fischle et al., 2003; Jacobs and Khorasanizadeh, 2002) . Thus, SUV39H, HP1, and AURKB are part of an epigenetic switch that mediates the transition between a repressive chromatin state (H3K9me2/3 and unmodified H3S10 and H3K14) and a more open active chromatin conformation (H3S10p and H3K14ac) (Liokatis et al., 2012) . The repressive combination of H3K9me2/3 and HP1 suppresses transcription of pericentromeric (Lehnertz et al., 2003; Martens et al., 2005) as well as telomeric repeats (Arnoult et al., 2012) . In contrast, the relatively rare occurrence of H3S10p during interphase at some genes has been related to enhanced transcription, probably by supporting an open chromatin structure (Ivaldi et al., 2007; Labrador and Corces, 2003; Lee et al., 2006; Lo et al., 2000; Nowak and Corces, 2004) . Furthermore, H3S10 phosphorylation was found during S phase for the first two cell divisions in embryogenesis (Teperek-Tkacz et al., 2010) and was linked to replication of heterochromatin in ESCs (Brown et al., 2013) .
Here, we set out to investigate if a functional role of H3S10p-mediated repeat transcription exists during interphase in mouse embryonic stem cells (ESCs) . We show that the production of centromeric RNA from minor satellite repeats (referred to here as cenRNA) is induced during the S phase of the cell cycle by AURKB-dependent H3S10 phosphorylation at subtelomeric regions. The resulting upregulation of cenRNA enhances the activity of the reverse transcriptase telomerase in trans to maintain telomeric repeats at the chromosome ends. Additionally, we show that AURKB interacts with both cenRNAs and TERT, the protein subunit of telomerase. Thus, our study identifies a mechanism by which a histone H3 phosphorylation-methylation switch controls cenRNA transcription and telomerase activity in a cell-cycle-specific manner.
RESULTS

AURKB Phosphorylates Centromeric and (Sub)telomeric Loci at Chromosomal p-Arms in ESCs during S Phase
We investigated the H3S10p pattern in mouse ESCs by immunofluorescence using the replication protein factor proliferating cell nuclear antigen (PCNA) as a cell-cycle marker. During the G1 phase, hardly any H3S10p was detectable in ESCs. However, distinct H3S10p foci became clearly visible during S phase adjacent to DAPI-dense regions ( Figure 1A ). The H3S10p foci persisted during G2 when the characteristic H3S10p pattern in the pericentric heterochromatin regions was established. AURKB was homogenously distributed throughout the nucleus during S phase as detected by immunostaining in ESCs with enrichments at the H3S10p foci, while the signal was absent during G1 (Figure 1A) . In contrast, the dot-like H3S10p distribution in S phase was not detectable in primary mouse embryonic fibroblasts (MEFs) ( Figure 1B ). In these cells AURKB expression was not detected during S phase but the enzyme became enriched at pericentric heterochromatin in G2 ( Figure 1B) .
The H3S10p-rich foci observed during S phase in ESCs were centered between the telomere and the centromere on the p-arm of each chromosome as inferred from a three-color staining for CENP-A, as a marker for the centromere and TRF2 to visualize the telomeres (Figure 2A ). From the confocal lasers scanning microscopy (CLSM) 3D-image stacks we selected samples that had the p-arm oriented in the x-y plane (Figure 2B, top panel) or aligned along the optical axis/z axis of the microscope (Figure 2B, bottom panel) . Comparison of the successive images taken along the z axis showed that the phosphorylation mapped to the chromosome p-arm and covered a region between the centromeres and telomeres that extended into the corresponding repeat sequences. Chromatin immunoprecipitation sequencing (ChIP-seq) of histone H3 and H3S10p showed an enrichment of H3S10p at centromeric repeats, but not at q arm subtelomeres, as inferred from the read distributions for synchronized ESCs (Figures S1A and S1B). In the unsynchronized cells, mitotic H3S10p covered the whole chromosome and dominated the signal with similar values for both regions.
Based on the above results we conclude that the H3S10p foci observed during S phase comprise a part of the centromeres, the subtelomeric regions, and a part of the telomere repeats at the chromosome p-arm. In the following, we refer to them as SPPs for (serine 10 phosphorylated p-arms) ( Figure 2C ). SPPs were also observed in the widely used Oct4-GiP ESCs (Lowell et al., 2006 ) that express GFP under the control of the Oct4 promoter and thus seem to be a general feature of mouse ESCs ( Figure S1C ).
When stem cells were treated with AURKB inhibitors such as reversine or ZM-447439, SPPs were essentially absent after 4 hr of treatment ( Figure S1D ). At a concentration of 1 mM, the AURKB inhibitor ZM-447439 blocked H3S10 phosphorylation during S phase, but not during mitosis, so that cells proliferated and experiments with long-term AURKB inhibition could be conducted. Under these conditions, ESCs displayed unchanged morphology, Oct4 expression, and cell-cycle properties for up to 15 weeks ( Figures S1E-S1I ). In addition, cell-cycle kinetics were comparable as shown by a release from a mitotic arrest ( Figure S1J) . Thus, at a 1-mM ZM-447439 inhibitor concentration, AURKB was selectively inhibited in S phase in the whole cell population and SPPs were lost without inducing cell-cycle defects, such as anaphase bridges ( Figure S2E ) or differentiation. The possibility to selectively inhibit AURKB activity at SPPs in S phase at low inhibitor concentrations ( Figure S2D ) can be rationalized by the increase of AURKB expression from S phase to a maximum in mitosis as shown by fluorescence-activated cell sorting (FACS) (Figures S2A and S2B ). In addition, we show that knockdown of AURKB also diminishes H3S10p in S phase in ESCs ( Figure S2C ). These results demonstrate that SPPs originate from the activity of AURKB acting as both an interphase and a mitotic kinase in ESCs. (A) Representative CLSM images of AURKB and H3S10p distribution in ESCs visualized by immunostaining during the cell cycle. PCNA-GFP was used as a marker for cell-cycle stages, displaying a homogenous distribution in G1 and a punctuate pattern due to the appearance of replication foci in S phase. More than 90% of the ESCs that displayed this S phase PCNA nuclear distribution also had H3S10p foci. At this cell-cycle stage, AURKB was also detected by immunostaining. The H3S10p foci persisted during G2, when H3S10p was enriched at DAPI-dense regions. Color-coding of merged image: H3S10P, green; AURKB, red; DAPI, blue. Scale bars, 5 mm. (B) Primary MEFs imaged as described for (A). AURKB and H3S10p were restricted to DAPI-dense regions in G2, and both were undetectable in G1 and S phase. Scale bars, 5 mm.
pattern by immunostaining. We detected SPPs in Suv39h dn iMEFs that were undistinguishable from those found in ESCs ( Figure S3) . Next, it was tested whether the SUV39H-mediated H3K9me2/3 modification suppresses phosphorylation of H3S10. To this end, wild-type SUV39H1 or the inactive H324L mutant and PCNA-RFP, a fusion protein of PCNA (proliferating cell nuclear antigen), and red fluorescent protein (RFP), were transfected into ESCs. Then, the number of SPPs was counted and compared to cells transfected only with PCNA-RFP (Figure 3A) . The overall number of SPPs was reduced from 23 ± 1 in wild-type cells to 8 ± 1 in Suv39h1 transfected cells (error bar corresponds to SEM; p value < 0.001, t test) ( Figure 3A) . The inactive Suv39h1 mutant did not influence the formation of SPPs. To exclude that the H3S10p antibody is negatively affected by H3K9me3, we assessed its specificity with a histone peptide array ( Figure S4A ). The results show that the antibody specifically detects H3S10p independent of the absence or presence of adjacent lysine 9 methylation.
HP1 isoforms alpha, beta, and gamma bind to both the centromere and the pericentric major satellite repeats, where its presence correlates with H3K9me3 and chromatin silencing (Fodor et al., 2010; Mü ller-Ott et al., 2014) . HP1 is released during G2 from the (peri)centromeres by the combination of H3S10p and H3K14ac modifications (Fischle et al., 2005; Mateescu et al., 2004) . Accordingly, we investigated if H3S10p in SPPs was accompanied by acetylation of lysine 14. We found that this was indeed the case in both ESCs and Suv39h dn iMEFs (Figure S4B ). Since the combination of H3S10p and H3K14ac is incompatible with HP1 binding, we evaluated the presence of HP1a at SPPs. We found that HP1a-rich foci formed at subtelomeric regions upon AURKB inhibition in S phase (Figures 3B and 3C) . Knockdown of AURKB resulted in the same relocalization of HP1a as AURKB inhibition ( Figure S4C ). In addition, H3K9me3 levels increased at SPPs upon AURKB inhibition ( Figure 3B ).
We conclude that HP1 and H3K9me3 accumulation-two prototypic features of a transcriptionally silent state-were absent in SPPs due to AURKB activity.
Since SPPs were only detectable at the short arm subtelomeric regions, we measured transcript levels from these regions in dependence of the H3S10p state modulated by the inhibition of AURKB with ZM-447439. Transcription of major and minor satellite repeats from the (peri)centromeres as well as the expression of the telomeric RNA TERRA were quantitated by real-time PCR. TERRA levels and major satellite transcripts (pcRNA) hardly changed after inhibition of AURKB for 48 hr, whereas minor satellite transcripts from the centromere (cen-RNA) were reduced by 54% ± 2% (p value < 0.01, t test) (Figure 3D) . Absence of genomic DNA was confirmed by real-time PCR ( Figure S4D ). Since it was reported that centromeric transcripts are double stranded (Martens et al., 2005) , we also checked strand-specific changes of cenRNA levels. Via cDNA synthesis with primers for the forward and the reverse transcript and subsequent real-time PCR quantification a reduction of both transcripts by 50% (p value < 0.05, t test) upon AURKB inhibition was measured ( Figure 3E ). Expression of cenRNA was followed through the cell cycle by synchronizing the ESCs with aphidicolin in G1. ESCs had hardly progressed 2 hr after released from the cell-cycle arrest, and the majority still resided at the G1/S border ( Figure S4E ). After 5 hr, most cells had entered S phase, and some had proceeded into G2. The presence of ZM-447439 did not affect cell-cycle progression ( Figure S4E ). The transcription level of the centromeric repeats was measured by real-time PCR relative to that of the control cells and normalized to Gapdh transcripts ( Figure S4F ). When AURKB was inhibited, cenRNA expression was independent of cell-cycle progression. Without the inhibitor, cenRNA expression reached its maximum 5 hr after release, which was 1.7-fold higher than in arrested cells and 2.5-fold higher than in Staining of CENP-A (blue) and H3S10p (green) and transfection of RFP-TRF2 (red) showed that the H3S10p foci were located near every centromere. Scale bars, 5 mm. (B) Stack of enlarged optical sections taken along the optical axis of the confocal microscopy images for two different chromosomes. The upper series shows images, in which H3S10p (green), the centromere (blue), and the telomere (red) are in the same image plane. The bottom series displays a view with the centromere, H3S10p, and the telomere appearing sequentially, i.e., the p-arm chromosome was located perpendicular to the image plane. Scale bars, 0.5 mm. (C) Scheme for chromosomal location of H3S10p foci. Serine 10 phosphorylated p-arm loci, referred to here as SPPs (green), were located between the centromere (blue) and telomere (red) of the p-arm and partially overlapped with the centromeric and telomeric regions. See also Figures S1 and S2.
ZM-447439-treated cells after release (p value < 0.05, t test). Thus, cenRNA expression was highest during S phase and dependent on AURKB.
AURKB Inhibition Leads to Telomere Shortening due to Lack of cenRNA It has been shown that chromatin organization plays an important role in telomere maintenance (Blasco, 2007) . As SPPs were located near the p-arm telomere and are needed for an open chromatin structure, we investigated whether SPPs and AURKB activity had an effect on telomere repeat maintenance at the p-arm. We determined total telomere length by fluorescence in situ hybridization against the telomere repeats coupled with flow cytometric quantification (flow-FISH). H3S10 phosphorylation was blocked in S phase with ZM-447439 for up to 15 weeks. Wild-type ESCs were compared with ZM-447439-treated cells after 4 and 15 weeks and wildtype cells that were cultured for 15 weeks in the absence of the AURKB inhibitor. The telomere length remained unchanged for untreated ESCs during this period. However, the ZM-447439-treated cells displayed a progressive telomere shortening over time ( Figure 4A ). After 4 weeks, telomeres were shortened by 6% ± 3% and by 11% ± 2% after 15 weeks. Telomere replication was not affected and still occurred early during the onset of S phase in both treated and untreated cells ( Figure S5A ). Figure S3 for SPPs in Suv39 dn cells and Figure S4A for specificity of the H3S10p antibody used here. (B) HP1 distribution in ESCs after AURKB inhibition. In ESC control cells, HP1 showed some enrichment at DAPI-dense regions and was otherwise homogenously distributed. Upon AURKB inhibition, HP1 formed distinct foci in S phase. In the merged image HP1 is shown in green, TRF2 in red, and DAPI in blue. Scale bars, 5 mm. ChIP-PCR shows enrichment of H3K9me3 at centromeres, but not at pericentric heterochromatin (PCH) after AURKB inhibition. Error bars correspond to the SD of three independent replicates. See also Figure S4C for siRNA knockdown of AURKB. (C) Localization of HP1 foci induced by AURKB inhibition. Sites with HP1 enrichment were located at the p-arm and overlapped with centromeres and telomeres (see white arrows) like the SPPs that were lost due to AURKB inhibition. In the merged image HP1 is shown in green, TRF2 in red, and CENP-A in blue. Scale bar, 5 mm. (D) RNA quantification after AURKB inhibition by real-time PCR. Values were normalized using b-actin, while Gapdh served as an internal control. A reduction of cenRNA in ZM-447439-treated cells was observed after 48 hr. Error bars correspond to the SD of three independent replicates. See also Figure S4D confirming the absence of genomic DNA. (E) Strand-specific real-time PCR of cenRNA. Both cenRNA f and cenRNA r transcripts were reduced upon AUKRB inhibition. Error bars correspond to the SD of three independent replicates. See also Figures S4E and S4F for cell-cycledependent cenRNA expression.
Next, telomere length was assessed on metaphase spreads to separately evaluate shortening at the p and q arm of each chromosome. An overall shortening of 15% ± 2% (p value < 0.001, t test) was measured for the ZM-447439-treated cells after 15 weeks as compared to their wild-type controls, which is in excellent agreement with the flow-FISH analysis. Interestingly, both telomeres at p and q arm were shortened (p value < 0.001, t test) (Figures 4B and 4C) , indicating that the H3S10p-dependent telomere maintenance mechanism acts in trans and not in cis. To exclude the possibility, that AURKB activity directly affects expression of telomerase, we confirmed that transcription of Tert and Terc encoding for the telomerase protein and RNA component, respectively, remained unchanged upon inhibition of AURKB ( Figures S5B and S5C ). Furthermore, we prepared two independent RNA-sequencing (RNA-seq) libraries from wild-type as well as from AURKB inhibitor-treated cells. Differential expression analysis with the DESeq software identified ten upregulated and no downregulated genes at the p < 0.01 significance level (Table S1 ). None of the upregulated genes had any apparent link to the observed interference with telomere maintenance.
We next tested in living cells if AURKB and TERT interact with each other, which might indicate a direct link between AURKB inhibition and telomere shortening. Mouse GFP-tagged TERT was tethered to lacO-arrays integrated at two chromosomes in a human U2OS cell line as described previously (Chung et al., 2011) . This led to a strong enrichment of RFP-AURKB at the two loci with tethered GFP-TERT ( Figure 4D ). In contrast, tethering only the GFP protein did not recruit AURKB. This demonstrates that AURKB interacts with TERT in living cells.
To examine whether telomerase activity was impaired by either AURKB inhibition or depletion of cenRNA, we measured telomerase activity with a quantitative telomeric repeat amplification protocol (TRAP) assay (Herbert et al., 2006) . We compared wild-type cells with ZM-447439-treated cells and cells transfected with two chimeric RNA-DNA oligomers for cen-RNA knockdown by RNase-H-mediated degradation (Liang et al., 2011) . One of these antisense oligonucleotides targeted the minor satellite forward transcript (cenRNA f ), while the other was complementary to the reversely transcribed RNA (cenRNA r ). Transfection with the two knockdown oligonucleotides resulted in a 70% reduction of cenRNA (p value < 0.001, t test) as measured by real-time PCR ( Figure S6A ). Both AURKB inhibition and cenRNA knockdown led to a reduction of telomerase activity of 50% and 40%, respectively (p value < 0.001, t test) ( Figure 4E ). The linear relationship between protein content and telomerase activity and dynamic range of the TRAP analysis is depicted in Figure S6B .
Interestingly, the Suv39h dn iMEFs showed a 22-fold higher expression level of cenRNA as compared to wild-type iMEFs (p value < 0.001, t test) ( Figure S5D ). In contrast, the Tert expression level was 22-fold lower in the Suv39h dn than in wild-type iMEFs (p value < 0.001, t test), while Terc expression and telomerase activity were similar in both cell types ( Figures S5D and S5E) . Accordingly, we speculate that telomerase activity in Suv39h dn cells is maintained by overexpression of cenRNA and AURKB ( Figure S5D ) to compensate for the much lower TERT levels.
Telomerase Activity Loss Can Be Rescued by Ectopic cenRNA Expression Since it was previously reported that cenRNA can enhance AURKB activity (Ferri et al., 2009) , we extended the cenRNA f and cenRNA r sequences with an RNA fragment that contained eight MS2 stem loops. The resulting MS2-cenRNA f and MS2-cenRNA r constructs were tethered to lacO-arrays via a fusion construct of LacI-RFP with the MS2 binding protein (LacI-RFP-MS2). Both MS2-cenRNA f and MS2-cenRNA r tethered to the lacO integration sites induced a clear recruitment of GFP-AURKB to these loci ( Figure 5A ). In contrast, binding of only the MS2 stem loop containing RNA to the lacO-arrays did not lead to an enrichment of GFP-AURKB. Based on these findings, we propose that the cenRNA-mediated enhancement of telomerase activity in ESCs occurs via interactions of a cenRNA-AURKB complex with the TERT subunit of telomerase. It is noted that this mechanism explains how AURKB inhibition and subsequent repression of cenRNA transcription via epigenetic silencing affects telomere repeat extension in trans.
To corroborate the functional relationship of cenRNAs and AURKB for regulating telomerase activity, we tested whether telomerase activity could be rescued by overexpression of these RNAs after AURKB inhibition. To this end, we cloned the minor satellite repeat sequence in an expression vector with an RNA polymerase III promoter and transfected AURKB inhibited cells twice over 48 hr. Expression of cenRNA was increased 3.5-fold and 1.8-fold over the mock control (empty vector) in transfected wild-type cells for the forward and reverse transcripts, respectively ( Figures S6C and S6D ). Telomerase activity was compared between wild-type cells and ZM-447439-treated cells. ZM-447439-treated cells were either untransfected or transfected with the empty vector (''Mock'') or cenRNA f and cenRNA r expression constructs ( Figure 5B ). Only cells expressing cenRNA f and cenRNA r simultaneously showed a significant rescue of telomerase activity compared to mock transfection and untransfected ZM-447439-treated cells. Thus, we conclude that the active form of cenRNA is double stranded.
Next, we in vitro translated AURKB and TERT and performed in vitro phosphorylation of TERT by AURKB. The telomerase activity was measured in the absence or presence of wild-type AURKB or inactive mutants, cenRNA, and major satellite RNA from the pericentromeric repeats. Telomerase activity was elevated by AURKB alone, but not by inactive AURKB mutants. It further increased by the addition of cenRNA, but not by the pcRNA repeat sequence of similar length from the major satellite repeat ( Figure 5C ). We conclude that cenRNA acts as an enhancer of an AURKB-mediated telomerase activation.
DISCUSSION
Centromeric minor satellite repeat sequences are actively transcribed to yield double-stranded transcripts of heterogeneous length from 25 up to several thousand base pairs, depending on the activity of the endoribonuclease Dicer (Kanellopoulou et al., 2005; Martens et al., 2005) . The overexpression of these RNAs referred to here as cenRNAs induce a chromosome segregation defect phenotype (Bouzinba-Segard et al., 2006) , but their specific cellular activities have remained enigmatic. Here, we show that AURKB-driven histone H3 serine 10 phosphorylation enhances cenRNA expression in mouse ESCs during the S phase of the cell cycle.
Since all mouse chromosomes are acrocentric, the centromeres are adjacent to the short arm telomere, with only a small variable linker region separating these two chromosomal regions (Guenatri et al., 2004; Kalitsis et al., 2006; Sasaki et al., 2013) . The center of the H3S10p-rich SPP loci was mapped by CLSM analysis to this subtelomeric region between the centromere and the telomere on the p-arm of each mouse chromosome but also extended to the flanking parts of the genome. ChIP-seq analysis of H3S10p showed that H3S10p was also enriched at the centromeric repeats themselves. Since inhibition of H3S10p affected only the transcription of the centromere repeats, but not that of major repeats or telomeric transcripts, we speculate that the SPPs contain promoter and/or enhancer regions for cenRNAs and that the phosphorylation also contributes to a transcription permissive chromatin structure within the repeats. Activation of their transcription by H3S10p could also involve H3K14ac, which was found to be associated with H3S10p in SPPs. Similar to the molecular events that occur during mitosis (Fischle et al., 2005) , HP1 became depleted from SPPs by the H3S10p and H3K14ac histone modifications, which is likely to promote transcription of the centromeric repeats. In contrast, AURKB inhibition resulted in HP1 binding to this region and silencing of cenRNA expression. The formation of SPPs was counteracted by the activity of SUV39H-driven H3K9 di/trimethylation as concluded from Suv39h dn fibroblasts having SPPs and high levels of cenRNA and the reduction of SPPs/H3S10p levels upon overexpression of SUV39H1 in ESCs.
Thus, the previously described network of SUV39H1/2-driven H3K9 di/trimethylation, the recognition of this modification by HP1, and the counteracting process of H3S10 phosphorylation followed by H3K14 acetylation operate in mouse ESCs to regulate cenRNA transcription during the S phase of the cell cycle. Upregulating cenRNA by this histone phosphorylation-methylation switch is of functional importance, since it is required for efficient telomere elongation. This is consistent with the finding that telomerase is mostly active during S phase after the telomeres have already been replicated (Já dy et al., 2006; Tomlinson et al., 2008; Zhao et al., 2008) .
Interestingly, it has been reported previously that telomerase processivity is affected by posttranslational histone modifications. Telomeric chromatin in differentiated mouse cells lacking telomerase activity is in a repressive heterochromatic state that is characterized by histone H3K9me3 and binding of HP1 (Benetti et al., 2007b; García-Cao et al., 2004) . Depletion of the histone methylases SUV4-20H1/H2 (catalyzing H4K20me3) and SUV39H1/H2 leads to aberrant telomere elongation (Benetti et al., 2007a (Benetti et al., , 2007b . At the same time, overexpression of SUV39H1 in mice results in telomere shortening (Petti et al., 2015) , which is in line with the finding reported in our study on suppression of SPPs and cenRNA expression by enhanced SUV39H1 activity. (B) Rescue of telomerase activity by cenRNA overexpression measured in a TRAP assay. While transfection with an empty plasmid showed no effect, simultaneous expression of cenRNA f and cenRNA r resulted in partial rescue of telomerase activity. Error bars correspond to the SD of three replicates. See also Figure S6 for overexpression of cenRNAs. (C) Telomerase activity is increased by AURKB and cenRNA. AURKB, TERT, and RNAs were in vitro translated and assembled in a phosphorylation buffer, and telomerase activity was measured in a TRAP assay. Activity was highest when TERT and TERC were mixed with AURKB and cenRNAs. Error bars correspond to the SD of three replicates.
In mouse ESCs, however, the telomeres lack these typical heterochromatin markers and telomerase is active. Induction of a heterochromatic chromatin state at SPPs by AURKB inhibition did affect telomere repeat extension in trans as shown by the telomere intensity analysis (Figures 4B and 4C) . Furthermore, we identified a specific mechanism in ESCs, by which SUV39H, H3K9me3, and HP1 counteracted the transcriptionally active chromatin state that was established during S phase via the H3S10p modification. In the active state, the extension of telomere repeats by telomerase was promoted via upregulation of cenRNA. Both AURKB inhibition and the knockdown of cenRNA resulted in a less active telomerase complex ( Figure 4E ). This conclusion is supported by the previously reported finding that knockdown of AURKB results in a reduced telomerase activity in human cancer cell lines (Cerone et al., 2011) . In the latter study, however, it remained unclear, whether this effect resulted from mitotic defects and/or cell-cycle arrest. In our study, AURKB was selectively inhibited in S phase and cell division was not impaired, and hence we can rule out cell-cycle effects on telomerase activity. Additionally, we did not observe changes in Tert or Terc expression when AURKB was inhibited.
Notably, long-term inhibition of AURKB resulted in a constant loss of telomere repeats in ESCs. Interestingly, Suv39h dn iMEFs had a 22-fold reduced Tert level, while the level of cenRNA was 22-fold increased as compared to the wild-type fibroblasts. This finding suggests that a low level of Tert expression was sufficient to ensure immortalization of Suv39h dn embryonic fibroblasts, as the higher cenRNA and AURKB levels in S phase provides sufficient telomerase activation at relatively low TERT concentrations. In this manner, a telomerase activity level could be obtained for Suv39h dn cells that was comparable to the wildtype immortalized fibroblasts.
In-vitro-translated telomerase was more efficient in the TRAP assay in combination with AURKB. This clearly shows that AURKB can indeed accelerate telomerase activity. In contrast to RNA from major satellite repeats, in-vitro-transcribed cenRNA further increased telomerase activity. This is fully consistent with our observation of reduced telomerase activity after knockdown of cenRNA ( Figures 4E and 5C ), while the overexpression of cenRNA partially rescued the loss of telomerase activity upon AURKB inhibition ( Figure 5B ).
Our findings link cenRNA, AURKB, and TERT activity and are summarized in the scheme depicted in Figure 6 . After replication of telomeres, H3S10 phosphorylation by AURKB induces cenRNA expression during S phase. Via interaction of the cenRNA-AURKB complex with TERT, the telomerase complex is activated in trans to compensate the loss of telomere repeats that occurred during replication. This activation step could involve the formation of telomerase dimers, which have been proposed to be more active in such a complex (Wenz et al., 2001 ) and/or an increase the enzyme's processivity by phosphorylation of TERT. Phosphorylation of TERT, e.g., by Akt, has been associated with telomerase activity (Haendeler et al., 2003; Seimiya et al., 1999) , whereas dephosphorylation by protein phosphatase 2A inhibits TERT in vitro (Li et al., 1997; Xi et al., 2013) . It is thus conceivable that AURKB regulates TERT activity by phosphorylation. Since cenRNA also enhances AURKB activity (Ferri et al., 2009) , the underlying network could include a feedback loop in which these transcripts further promote H3S10p formation. SUV39H promotes a chromatin state in which H3K9me3 and HP1 binding suppress H3S10p and cenRNA expression as inferred from the analysis of Suv39h dn cell and overexpression of SUV39H1. Thus, via regulating cenRNA expression by a cell-cycle-dependent histone modification switch, telomerase activity in mouse ESCs is synchronized with telomere replication. Modulating telomerase activity in this manner has a number of implications for tumorigenesis as well as reprogramming of somatic cells, since activation and regulation of telomere maintenance is a crucial step in both processes. Therefore, we anticipate that investigating the role of the epigenetic network revealed here in other cellular systems will AURKB expression leads to the formation of SPPs between the centromere and telomere, which induces cenRNA expression. In turn, cenRNAs bind to AURKB and this complex interacts with TERT to enhance telomerase activity needed for efficient telomere elongation. Telomerase activation is impaired by AURKB inhibition and cenRNA knockdown. In addition, SUV39H activity promotes H3K9me3 and HP1 binding to induce a chromatin state that counteracts H3S10p formation during S phase and silences cenRNA expression.
provide valuable information on the linkage between changes of (sub)telomeric and/or centromeric chromatin and functional cell states via cenRNA effector transcripts.
EXPERIMENTAL PROCEDURES
Cell Culture 129/Ola ESCs (Mallm et al., 2010) used for this study were cultured in Powerstem ESPRO1 (PAN) on gelatin-coated surfaces. GIP-ESCs were maintained in ESGRO complete (Millipore) without feeders on gelatin. 129/Ola-Hsd MEFs were generated from pregnant embryonic day 13.5 (E13.5) mice and cultured in DMEM supplemented with 10% fetal calf serum and glutamine up to passage five. The same medium was used to culture SUV39H1/h2 double-null cells and wild-type iMEFs (Peters et al., 2001 ).
Immunofluorescence and Western Blotting
For immunostaining and transfection, cells were seeded on Matrigel-coated coverslips. Vectors for overexpression of RFP-TRF2, GFP-PCNA, RFP-PCNA, GFP-SUV39H1, and the GFP-SUV39H1 H324L inactive mutant were transfected with lipofectamine 2000. Fixed and stained cells were mounted with Prolong containing DAPI (Invitrogen) and examined using a Leica TCS SP5 confocal laser-scanning microscope equipped with a 633/1.4 numerical aperture oil-immersion objective lens (Leica Microsystems CMS). For AUKRB knockdown, small interfering RNA (siRNA) (Ambion, s74513) was transfected with lipofectamine 3000 and cells were fixed 36 hr after transfection.
For immunostaining and western blots, the following antibodies were used: AURKB (6/AIM-1, BD Bioscience), CENP-A (2048, Cell Signaling), GAPDH (AM4300, Ambion), histone H3S10p (ab14955, Abcam, for all experiments except immunofluorescence with AURKB, when ab5176 [Abcam] was used), histone H3S10pK14ac (07-081, Millipore), HP1-alpha (2HP-1H5, Euromedex), OCT4 (ab279985, Abcam), TERT (H-231, Santa Cruz). The specificity of the ab14955 H3S10p antibody was verified with the ''MODified Histone Peptide Array'' (Active Motif) according to the manufacturer's instructions ( Figure S4A) .
Counting of H3S10p foci after transfection with GFP-SUV39H1 and GFP-SUV39H1H324L mutant was done using ImageJ software. First, the background of the H3S10p staining in the nucleus was determined and a threshold was applied, which was three times higher then the background. Then, H3S10p foci were automatically detected within the nucleus with the constraint that their size had to be in the range from 0.05 to 2 mm 2 .
Total RNA Extraction and Real-Time PCR Total RNA was extracted with the RNeasy kit (QIAGEN) following the manufacturer's instructions. Total RNA was subsequently digested with DNase I for 1 hr to ensure depletion of contaminating genomic DNA. 2 mg total RNA was used for cDNA first-strand synthesis using superscript II reverse transcriptase (Invitrogen), which was followed by RNase H treatment. For quantification, a cDNA standard was prepared that included five samples ranging from 25 ng/ml to 0.35 ng/ml. The standard curve was determined from real-time PCR with 2 ml of each concentration using the SYBR Green I kit by Roche and the StepOne RT-PCR system (Applied Biosystems) and subsequently used to quantify the target cDNA. The following program was used for amplification: 95 C for 10 min followed by 35 cycles with 95 C, 60 C, and 72 C each for 10 s. Three biological independent samples were used for each primer pair with three replicates. Gapdh was used for normalization, and b-actin served an internal control. Errors given in the graphics correspond to SEM. Primers used for real-time PCR are listed in Table 1 .
Cell-Cycle and Telomere-Length Flow-FISH Analysis by FACS
For cell-cycle analysis, cells were harvested and fixed with 70% ethanol for 2 hr on ice. After resuspension in staining buffer (PBS containing 100 mg/ml RNase and 0.5 mM TO-PRO3), cells were analyzed with FACS Canto II. Cellcycle stages were fitted to DNA content profiles with the Weasel flow cytometry data analysis software. For flow-FISH, cells were permeabilized with 0.25% Triton after ethanol fixation. Cells were washed with a buffer containing 5% glucose, 10 mM HEPES (pH 8.0), and 0.1% BSA and were resuspended in hybridization buffer (75% deionized formamide, 20 mM Tris-HCl [pH 7.4], 20 mM NaCl, and 0.1% BSA) with 55 nM PNA (peptide nucleic acid) fluorescein isothiocyanate telC probe (Pangene). After 15 min at 87 C, hybridization was allowed for 90 min at room temperature, and cells were subsequently washed with a buffer containing 70% formamide, 0.1% BSA, 0.1% Tween-20, and 20 mM Tris-HCl (pH 7.4) three times and then washed with a buffer containing 5% glucose, 10 mM HEPES (pH 7.4), 0.1% BSA, and 0.1% Tween-20. Cells were resuspended in staining buffer and analyzed the same day. For each sample, three independent hybridizations were performed. Protein expression of AURKB was measured by fixing cells with 1% paraformaldehyde (PFA) for 10 min on ice, followed by ethanol fixation for 2 hr. After permeabilizing with 0.25% Triton, the AURKB antibody was diluted 1:200 in 1% BSA/PBS and incubated overnight followed by an Alexa 488 secondary antibody. Cells were resuspensed in staining buffer (PBS containing 100 mg/ ml RNase and 0.5 mM TO-PRO3) and analyzed with FACS Canto II.
For synchronization and release from a mitotic block, cells were arrested with 200 nM nocodazole for 24 hr and released by three washes and maintenance in medium.
Metaphase Spreads and Telomere FISH
Colcemid was added to the medium to a concentration of 0.02 mg/ml for 2 hr. Cells were washed and incubated in 0.5% KCl and then fixed in methanol and glacial acetic acid. Fixed nuclei were spotted in coverslips and washed with ethanol. Cell nuclei were incubated with telomere PNA probes at 80 C for 3 min after sealing the coverslips with Fixogum. Hybridization took place overnight. After washes with 70% formamide, 23 SSC buffer (300 mM sodium chloride and 30 mM sodium citrate), 0.13 SSC at 55 C, and 0.05% Tween in 23 SSC, metaphase spreads were dried with ethanol and eventually mounted with Prolong (Invitrogen). For wild-type and inhibitor-treated cells, a minimum of 2,000 telomeres were analyzed from two technical replicates.
Pictures were taken at the same day with the same laser settings. Pixel intensities of telomere probes were measured with ImageJ.
RNA-Seq
Total RNA was purified as described above. Ribosomal RNA was removed with the RiboZero kit (Epicenter) following the manufacturer's instructions. After fragmentation with the RNA Fragmentation Reagent (Ambion), cDNA was generated with random primers and superscript II reverse transcriptase (Invitrogen). After second-strand synthesis, the fragments were cloned into an Illumina sequencing library according to standard protocols. Two biologically independent samples of wild-type and treated cells were submitted for sequencing. After mapping with bowtie, differential expression was calculated 
Gapdh fwd TATGTCGTGGAGTCTACTGG
Gapdh rev ACACCCATCACAAACATGGG
Tert fwd TAGAGGATTGCCACTGGCTCC
Tert rev AGCTGTACCACGTATGTGTCC
Terc fwd GGTTCTGGTCTTTTGTTCTCCG
Terc rev TTTTGAGGCTCGGGAACGCG
with DESeq that was incorporated in the Genomatix software suite as described previously (Teif et al., 2012) .
ChIP-Seq of H3S10p
ESCs were synchronized with 3 mg/ml aphidicolin for 20 hr. The cells were released for 3 hr and subsequently cross-linked with 1% PFA. Cell nuclei were prepared using a swelling buffer (25 mM HEPES [pH 7.8], 1 mM MgCl 2 , 10 mM KCl, 0.1% NP-40, and 1 mM DTT). Chromatin was sheared to mononucleosomal fragments with a Covaris S220 sonicator. After immunoglobulin G preclearance, the sheared chromatin was incubated with 4 mg of either H3S10p (ab14955, Abcam) or histone H3 (ab4729, Abcam) antibody and magnetic protein G beads overnight. The beads were washed with sonication buffer (10 mM Tris-HCl [pH 8.0], 200 mM NaCl, 1 mM EDTA, 0.5% Nlauroylsarcosine, and 0.1% Na-deoxycholate), high-salt buffer (50 mM HEPES [pH 7.9], 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, and 0.1% SDS), lithium buffer (20 mM Tris-HCl [pH 8.0], 1 mM EDTA, 250 mM LiCl, 0.5% NP-40, and 0.5% Na-deoxycholate), and 10 mM Tris-HCl (pH 6.8). Next, chromatin was eluted from the protein G magnetic beads and the crosslink was reversed overnight at 65 C. After RNase A and proteinase K digestion, the DNA was purified and cloned into a multiplexed Illumina library according to standard protocols. Sequenced 50-bp reads were mapped to the mm9 assembly with customized bowtie indices. The number of mapped reads was normalized to the total number of reads.
Quantification of Telomerase Activity with the TRAP Assay
Cells were harvested and lysed in TRAP lysis buffer for 30 min, which contained 10 mM Tris-HCl (pH 7.4), 1 mM MgCl 2 ,1 mM EDTA, 1% (v/v) NP-40, 0.25 mM sodium deoxycholate, 10% (v/v) glycerol, 150 mM NaCl, 5 mM mercaptoethanol, and 1 U/ml Ribolock RNase inhibitor (Fermentas). After centrifugation, the supernatant was collected and total protein concentration was measured using the BCA assay (Thermo Scientific). A standard was prepared that ranged from 0.125 ng/ml to 0.004 ng/ml total protein, and the samples were diluted in lysis buffer to gain a concentration of 0.04 ng/ml. For each TRAP reaction, 2 ml of the lysate were incubated with SYBR Green PCR master mix kit (Applied Biosystems), 5 ng/ml TS primer (5 0 -AATCCGTCGA GCAGAGTT-3 0 ), 5 ng/ml ACX primer (5 0 -GCGCGGCTTACCCTTACCCTTACCCT AACC-3 0 ), 1 mM EGTA, and 1 U/ml Ribolock for 30 min at 30 C. PCR was then run for 35 cycles with 15 s at 95 C and 60 s at 60 C.
The measured PCR threshold cycle (Ct) was transformed into an activity value according to the standard curve. This allowed relative quantification of the cell lysates with equal total protein concentration. Errors are given as the SD of the three biological replicates, and the Student's t test was used for statistical testing.
For rescue experiments, cells were treated with the AURKB inhibitor for 48 hr, then seeded on gelatin-coated 12-well plates and transfected with the pBS/U6 plasmids (Grimm et al., 2006) within 3 hr. The cenRNAs were cloned into the pBS/U6 plasmid via the Bbs I cloning site in both forward and reverse directions. Expression of GFP from the same plasmid under the CMV promoter was used to judge the transfection efficiency. The amount of cenRNA was determined by PCR as described above. For each sample, three biological replicates were performed. At 48 hr after transfection, cells were harvested and subjected to a quantitative TRAP assay. Protein and RNA Recruitment and Interaction Analysis GFP-tagged TERT was recruited via a LacI repressor-GFP binding domain fusion protein to lacO-arrays integrated in telomerase-negative U2OS cells as described previously (Chung et al., 2011; Jegou et al., 2009 ). Co-recruitment of RFP-AURKB was measured 24 hr after transfection. Cells were fixed and mounted with Prolong antifade reagent (Life Technologies). Images were taken with a Leica SP5 microscope, and pictures were analyzed with ImageJ. Signal intensity of RFP-AURKB was measured at lacO arrays and regions adjacent to the lacO arrays. Positive recruitment was defined as the signal increase at the lacO array by >1.5-fold as compared to adjacent regions. EGFP recruited to lacO-arrays was used as a negative control. For RNA recruitment experiments, one centromere repeat was fused to eight MS2 stem loops in forward and reverse orientation. The fusion construct LacI-RFP-MS2-coat protein was transfected with the tagged centromere repeats and GFP-AURKB. Cells were fixed and imaged as described above. For statistical analysis of AURKB recruitment either by TERT or by cenRNA, the Fisher's exact test was used.
In Vitro Phosphorylation of TERT Open reading frames of AURKB and TERT were cloned into pET28(a)+ and used for in vitro translation with rabbit reticulocyte lysates (RLL; Promega). For in vitro translation of AURKB, 1 mg of plasmid was used, and for TERT, 1.5 mg plasmid plus 250 ng in-vitro-transcribed TERC was used and incubated according to the manufacturer's instructions. AURKB mutants K111M and D205A were generated by site-directed mutagenesis.
Lysates were directly used for in vitro phosphorylation using 2 ml AURKB lysate and 10 ml TERT lysate in phosphorylation buffer (10 mM HEPES [pH 7.4], 150 mM NaCl, 10 mM MgCl 2 , and 1 mM EGTA) for 30 min at 37 C. The phosphorylation reaction was then diluted in TRAP lysis buffer (1:25) and used for a quantitative TRAP assay as described above.
ACCESSION NUMBERS
The RNA-seq and ChIP-seq data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) under accession number GSE67133. (D) Same as panel C but for cenRNA r . Over-expression of this RNA was about two fold.
SUPPLEMENTAL INFORMATION
Error bars represent the standard deviation of three independent experiments. Ten genes were identified using DESeq with two replicates for treated and untreated cells each that were significantly upregulated. No gene was found to be down-regulated by at least 2-fold.
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